8-K: Cardinal Health Appoints Robert Musslewhite and Sudhakar Ramakrishna to Board of Directors

Cardinal Health has elected Robert Musslewhite and Sudhakar Ramakrishna as independent directors, effective March 7, 2025, to enhance its board with expertise in technology, data analytics, and cybersecurity.

Summary

• Cardinal Health has appointed Robert W. Musslewhite and Sudhakar Ramakrishna to its Board of Directors, effective March 7, 2025.
• Both will serve until the 2025 annual meeting of shareholders.
• Mr. Musslewhite, former CEO of Definitive Healthcare Corp., will serve on the Audit and Human Resources and Compensation Committees.
• Mr. Ramakrishna, President and CEO of SolarWinds Corporation, will serve on the Audit and Risk Oversight Committees.
• The board has determined that both appointees are independent under NYSE rules and SEC regulations.
• They will receive compensation consistent with other non-employee directors, as detailed in the 2024 proxy statement.
• The appointments were announced in a news release issued on March 10, 2025.

Sentiment

Score: 7

Explanation: The announcement is positive, highlighting the addition of experienced and qualified individuals to the board. It suggests a strategic focus on technology and data, which is generally viewed favorably.

Positives

• The addition of Musslewhite and Ramakrishna brings significant expertise in technology, data analytics, and cybersecurity to the Cardinal Health board.
• Their experience as CEOs of publicly traded companies and board members of other organizations is expected to provide valuable insights.
• The appointments align with Cardinal Health's focus on navigating complex and rapidly evolving environments.

Future Outlook

The new directors are expected to contribute to Cardinal Health's strategic direction and growth, particularly in technology and data-driven solutions.

Management Comments

• Gregory Kenny, Chairman of the Board, stated that Musslewhite's expertise in data and Ramakrishna's leadership in technology and business strategy will be a tremendous asset to the company.
• Jason Hollar, CEO of Cardinal Health, noted that their backgrounds in technology will be instrumental in helping the company navigate complex and rapidly evolving environments.

Industry Context

The appointments reflect a growing trend in the healthcare industry to incorporate technology and data analytics expertise at the board level to drive innovation and strategic decision-making.

Comparison to Industry Standards

• Many large healthcare companies, such as UnitedHealth Group (where Musslewhite previously worked at OptumInsight), are increasingly focused on data analytics and technology.
• SolarWinds Corporation, where Ramakrishna is currently CEO, is a major player in the IT management software space, similar to companies like Datadog and New Relic.
• The appointment of independent directors with technology backgrounds is a common practice among NYSE-listed companies to ensure board diversity and expertise.

Management Changes

Stakeholder Impact

• Shareholders may view the appointments positively, anticipating enhanced strategic direction and innovation.
• Employees may benefit from the expertise of the new directors in technology and data-driven solutions.
• The appointments could strengthen Cardinal Health's relationships with customers and suppliers through improved technology and data capabilities.

Next Steps

• Messrs. Musslewhite and Ramakrishna will serve on their respective committees.
• They will participate in the 2025 annual meeting of shareholders.

Key Dates